CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 44340-44757 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T294","span":{"begin":0,"end":312},"obj":"Sentence"},{"id":"TextSentencer_T295","span":{"begin":313,"end":417},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These results reflect the persistence of an IM-like humoral immune response to EBV in MS, supporting the epidemiological data on an increased risk of MS for individuals with a clinical history of IM and suggesting an unsatisfactory control of EBV infection in MS. [1] Sundström P, Nyström M, Ruuth K, Lundgren E. Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis."}

{"project":"Epistemic_Statements","denotations":[{"id":"T100","span":{"begin":0,"end":417},"obj":"Epistemic_statement"}],"text":"These results reflect the persistence of an IM-like humoral immune response to EBV in MS, supporting the epidemiological data on an increased risk of MS for individuals with a clinical history of IM and suggesting an unsatisfactory control of EBV infection in MS. [1] Sundström P, Nyström M, Ruuth K, Lundgren E. Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T294","span":{"begin":0,"end":312},"obj":"Sentence"},{"id":"T295","span":{"begin":313,"end":417},"obj":"Sentence"}],"text":"These results reflect the persistence of an IM-like humoral immune response to EBV in MS, supporting the epidemiological data on an increased risk of MS for individuals with a clinical history of IM and suggesting an unsatisfactory control of EBV infection in MS. [1] Sundström P, Nyström M, Ruuth K, Lundgren E. Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T186","span":{"begin":86,"end":88},"obj":"Body_part"},{"id":"T187","span":{"begin":150,"end":152},"obj":"Body_part"},{"id":"T188","span":{"begin":260,"end":262},"obj":"Body_part"}],"attributes":[{"id":"A186","pred":"uberon_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A187","pred":"uberon_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A188","pred":"uberon_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"These results reflect the persistence of an IM-like humoral immune response to EBV in MS, supporting the epidemiological data on an increased risk of MS for individuals with a clinical history of IM and suggesting an unsatisfactory control of EBV infection in MS. [1] Sundström P, Nyström M, Ruuth K, Lundgren E. Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T94844","span":{"begin":86,"end":88},"obj":"Disease"},{"id":"T245","span":{"begin":150,"end":152},"obj":"Disease"},{"id":"T60249","span":{"begin":243,"end":256},"obj":"Disease"},{"id":"T8920","span":{"begin":247,"end":256},"obj":"Disease"},{"id":"T66358","span":{"begin":260,"end":262},"obj":"Disease"},{"id":"T82209","span":{"begin":398,"end":416},"obj":"Disease"},{"id":"T12092","span":{"begin":86,"end":88},"obj":"Disease"},{"id":"T86800","span":{"begin":150,"end":152},"obj":"Disease"},{"id":"T83551","span":{"begin":243,"end":256},"obj":"Disease"},{"id":"T28911","span":{"begin":247,"end":256},"obj":"Disease"},{"id":"T96010","span":{"begin":260,"end":262},"obj":"Disease"},{"id":"T91367","span":{"begin":398,"end":416},"obj":"Disease"}],"attributes":[{"id":"A50277","pred":"mondo_id","subj":"T94844","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A67811","pred":"mondo_id","subj":"T245","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A33092","pred":"mondo_id","subj":"T60249","obj":"http://purl.obolibrary.org/obo/MONDO_0005111"},{"id":"A90152","pred":"mondo_id","subj":"T8920","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A73839","pred":"mondo_id","subj":"T66358","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A5870","pred":"mondo_id","subj":"T82209","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A85777","pred":"mondo_id","subj":"T12092","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A75861","pred":"mondo_id","subj":"T86800","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A35923","pred":"mondo_id","subj":"T83551","obj":"http://purl.obolibrary.org/obo/MONDO_0005111"},{"id":"A14389","pred":"mondo_id","subj":"T28911","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A35656","pred":"mondo_id","subj":"T96010","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A92756","pred":"mondo_id","subj":"T91367","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"These results reflect the persistence of an IM-like humoral immune response to EBV in MS, supporting the epidemiological data on an increased risk of MS for individuals with a clinical history of IM and suggesting an unsatisfactory control of EBV infection in MS. [1] Sundström P, Nyström M, Ruuth K, Lundgren E. Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis."}